Katherine S F Damme1,2, Jason Schiffman3, Lauren M Ellman4, Vijay A Mittal1,2,5,6,7. 1. Department of Psychology, Northwestern University, Evanston, IL. 2. Institute for Innovations in Developmental Sciences (DevSci), Northwestern University, Evanston and Chicago, IL. 3. University of Maryland, Baltimore, MD. 4. Department of Psychology, Temple University, Philadelphia, PA. 5. Department of Psychiatry, Northwestern University, Chicago, IL. 6. Medical Social Sciences, Northwestern University, Chicago, IL. 7. Institute for Policy Research (IPR), Northwestern University, Chicago, IL.
Abstract
BACKGROUND: Sensorimotor abnormalities precede and predict the onset of psychosis. Despite the practical utility of sensorimotor abnormalities for early identification, prediction, and individualized medicine applications, there is currently no dedicated self-report instrument designed to capture these important behaviors. The current study assessed and validated a questionnaire designed for use in individuals at clinical high-risk for psychosis (CHR). METHODS: The current study included both exploratory (n = 3009) and validation (n = 439) analytic datasets-that included individuals identified as meeting criteria for a CHR syndrome (n = 84)-who completed the novel Sensorimotor Abnormalities and Psychosis-Risk (SMAP-R) Scale, clinical interviews and a finger-tapping task. The structure of the scale and reliability of items were consistent across 2 analytic datasets. The resulting scales were assessed for discriminant validity across CHR, community sample non-psychiatric volunteer, and clinical groups. RESULTS: The scale showed a consistent structure across 2 analytic datasets subscale structure. The resultant subscale structure was consistent with conceptual models of sensorimotor pathology in psychosis (coordination and dyskinesia) in both the exploratory and the validation analytic dataset. Further, these subscales showed discriminant, predictive, and convergent validity. The sensorimotor abnormality scales discriminated CHR from community sample non-psychiatric controls and clinical samples. Finally, these subscales predicted to risk calculator scores and showed convergent validity with sensorimotor performance on a finger-tapping task. CONCLUSION: The SMAP-R scale demonstrated good internal, discriminant, predictive, and convergent validity, and subscales mapped on to conceptually relevant sensorimotor circuits. Features of the scale may facilitate widespread incorporation of sensorimotor screening into psychosis-risk research and practice.
BACKGROUND:Sensorimotor abnormalities precede and predict the onset of psychosis. Despite the practical utility of sensorimotor abnormalities for early identification, prediction, and individualized medicine applications, there is currently no dedicated self-report instrument designed to capture these important behaviors. The current study assessed and validated a questionnaire designed for use in individuals at clinical high-risk for psychosis (CHR). METHODS: The current study included both exploratory (n = 3009) and validation (n = 439) analytic datasets-that included individuals identified as meeting criteria for a CHR syndrome (n = 84)-who completed the novel Sensorimotor Abnormalities and Psychosis-Risk (SMAP-R) Scale, clinical interviews and a finger-tapping task. The structure of the scale and reliability of items were consistent across 2 analytic datasets. The resulting scales were assessed for discriminant validity across CHR, community sample non-psychiatric volunteer, and clinical groups. RESULTS: The scale showed a consistent structure across 2 analytic datasets subscale structure. The resultant subscale structure was consistent with conceptual models of sensorimotor pathology in psychosis (coordination and dyskinesia) in both the exploratory and the validation analytic dataset. Further, these subscales showed discriminant, predictive, and convergent validity. The sensorimotor abnormality scales discriminated CHR from community sample non-psychiatric controls and clinical samples. Finally, these subscales predicted to risk calculator scores and showed convergent validity with sensorimotor performance on a finger-tapping task. CONCLUSION: The SMAP-R scale demonstrated good internal, discriminant, predictive, and convergent validity, and subscales mapped on to conceptually relevant sensorimotor circuits. Features of the scale may facilitate widespread incorporation of sensorimotor screening into psychosis-risk research and practice.
Authors: Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods Journal: Schizophr Bull Date: 2003 Impact factor: 9.306
Authors: R C Gur; J D Ragland; P J Moberg; T H Turner; W B Bilker; C Kohler; S J Siegel; R E Gur Journal: Neuropsychopharmacology Date: 2001-11 Impact factor: 7.853
Authors: Vijay A Mittal; Melita Daley; Marisa F Shiode; Carrie E Bearden; Joseph O'Neill; Tyrone D Cannon Journal: Schizophr Res Date: 2010-08-21 Impact factor: 4.939
Authors: Jessica A Bernard; Derek J Dean; Jerillyn S Kent; Joseph M Orr; Andrea Pelletier-Baldelli; Jessica R Lunsford-Avery; Tina Gupta; Vijay A Mittal Journal: Hum Brain Mapp Date: 2014-01-24 Impact factor: 5.038
Authors: K Juston Osborne; Wendy Zhang; Jaclyn Farrens; McKena Geiger; Brian Kraus; James Glazer; Robin Nusslock; Emily S Kappenman; Vijay A Mittal Journal: J Psychopathol Clin Sci Date: 2022-05
Authors: D Kimhy; C Tay; J Vakhrusheva; K Beck-Felts; L H Ospina; C Ifrah; M Parvaz; J J Gross; M N Bartels Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-01-03 Impact factor: 5.760
Authors: Tina Gupta; Gregory P Strauss; Henry R Cowan; Andrea Pelletier-Baldelli; Lauren M Ellman; Jason Schiffman; Vijay A Mittal Journal: Biol Psychiatry Glob Open Sci Date: 2021-06-02